2021-01-11,BeiGene Announces Collaboration with Novartis to Develop and Commercialize Anti-PD-1 Antibody Tislelizumab
2021-01-11,"Strand Therapeutics and BeiGene Enter into Agreement to Develop Solid Tumor Immuno-Oncology Therapeutics Based on Strands Next-Generation, Multi-Functional mRNA Technology"
2021-01-07,BeiGene to Present at the J.P. Morgan 39th Annual Healthcare Conference
2020-12-27,BeiGene Announces Inclusion of Three Innovative Oncology Products in China National Reimbursement Drug List (NRDL)
2020-12-14,Is BGNE A Good Stock To Buy Now?
2020-12-11,Hudson Executive Reports Cardtronics Stake
2020-12-07,BeiGene Announces the Approval in China of BLINCYTO® (Blinatumomab) for Injection for Adult Patients with Relapsed or Refractory B-Cell Precursor Acute Lymphoblastic Leukemia (ALL)
2020-12-07,BeiGene Presents Clinical Data on BRUKINSA® (Zanubrutinib) in B-Cell Malignancies and Waldenströms Macroglobulinemia at the 62nd ASH Annual Meeting
2020-12-06,BeiGene Announces Data on BRUKINSA® (Zanubrutinib) from Phase 2 Trial in Marginal Zone Lymphoma and Phase 3 Trial in Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma at the 62nd ASH Annual Meeting
2020-12-01,BeiGene Announces Pricing of Public Offering by Selling Shareholders
2020-12-01,BeiGene Launches Proposed Public Offering by Selling Shareholders
2020-11-23,BeiGene to Present at the Piper Sandler 32nd Annual Virtual Healthcare Conference
2020-11-20,"The Daily Biotech Pulse: Amarin Surges On Vascepa Data, Mesoblast Rallies On Novartis Deal, Decision Day For Eiger"
2020-11-19,BeiGene Announces the Approval of XGEVA® (Denosumab) in China for the Prevention of Skeletal-Related Events in Patients With Bone Metastases From Solid Tumors and in Patients With Multiple Myeloma
2020-11-17,BeiGene Announces that RATIONALE 303 Trial of Tislelizumab in Non-Small Cell Lung Cancer Met the Primary Endpoint of Overall Survival at Interim Analysis
2020-11-07,"US$260 - That's What Analysts Think BeiGene, Ltd. (NASDAQ:BGNE) Is Worth After These Results"
2020-11-05,BeiGene Reports Third Quarter 2020 Financial Results
2020-11-05,BeiGene Announces Data on BRUKINSA® (Zanubrutinib) and Tislelizumab to Be Presented at the 62nd ASH Annual Meeting
2020-10-09,How Should Investors React To BeiGene's (NASDAQ:BGNE) CEO Pay?
2020-10-06,BioAtla and BeiGene Revise Global Development and Commercialization Agreement for Novel Conditionally Active Biologic CTLA-4 Candidate BA3071
2020-10-01,"All You Need to Know About BeiGene, Ltd. (BGNE) Rating Upgrade to Buy"
2020-10-01,"BeiGene's Shares March Higher, Can It Continue?"
2020-09-27,3 Top Biotech Stocks to Buy Right Now
2020-09-21,Leap Therapeutics and BeiGene Announce First Patient Dosed in Study of DKN-01 in Combination with Tislelizumab for the Treatment of Metastatic Gastric or Gastroesophageal Junction Cancer
2020-09-17,BeiGene Presents Data at ESMO Virtual Congress 2020 on Phase 3 Trial of Tislelizumab in First-Line Non-Squamous Non-Small Cell Lung Cancer and Phase 2 Trial of Pamiparib in Advanced Ovarian Cancer
2020-09-10,BeiGene to Present at the Morgan Stanley 18th Annual Global Healthcare Conference
2020-09-09,BeiGene Announces Acceptance and Priority Review by Health Canada of New Drug Submission for BRUKINSA® (zanubrutinib) in Waldenströms Macroglobulinemia
2020-09-04,BeiGene Announces Inclusion of Its Shares in the Shanghai-Hong Kong and Shenzhen-Hong Kong Stock Connect Programs
2020-08-27,"The Daily Biotech Pulse: Liver Congress Underway, FDA Approves Companion Diagnostic Test For Clovis Cancer Drug, EUA For Abbott's $5, 15-Minute COVID-19 Test"
2020-08-27,BeiGene Announces Exclusive License Agreement for Neutralizing COVID-19 Antibodies Developed by Singlomics Biopharmaceuticals
2020-08-25,"BeiGene Appoints Corsee Sanders, Ph.D. to its Board of Directors"
2020-08-24,"Bio-Thera Solutions and BeiGene Announce License, Distribution, and Supply Agreement for Avastin® (Bevacizumab) Biosimilar BAT1706 in China"
2020-08-07,"What Makes BeiGene, Ltd. (BGNE) a New Buy Stock"
2020-08-06,BeiGene Reports Second Quarter 2020 Financial Results
2020-08-05,BeiGene Announces Data on Tislelizumab and Pamiparib to Be Presented at the 2020 European Society for Medical Oncology (ESMO) Virtual Congress
2020-07-27,Priority Review Granted to BeiGenes New Drug Application of Pamiparib in Ovarian Cancer in China
2020-07-24,13Ds Filings
2020-07-20,"BeiGene, Assembly Bio Ink $540M China HBV Deal; Shares Surge In Pre-Market"
2020-07-20,Assembly Biosciences and BeiGene Announce License and Collaboration Agreement in China for Assemblys Portfolio of Three Clinical-Stage Core Inhibitors for Chronic Hepatitis B Infection
2020-07-17,BeiGene Announces Acceptance of a New Drug Application of Pamiparib in Ovarian Cancer in China
2020-07-16,"Biotech Stock Roundup: GILD, MRNA Give Coronavirus Treatment Updates & More"
2020-07-15,BeiGene Announces Closing of Approximately $2.08 Billion Registered Direct Offering
2020-07-15,Hillhouse Plans to Invest $1 Billion In Beigenes Share Sale
2020-07-14,Why BeiGene Stock Jumped Today
2020-07-14,BeiGene (BGNE) in Focus: Stock Moves 8.7% Higher
2020-07-13,Why BeiGene's Stock Is Trading Higher Today
2020-07-13,Amgen (AMGN) Invests Further in China-Based Oncology Partner
2020-07-13,Here's Why BeiGene (NASDAQ:BGNE) Can Manage Its Debt Despite Losing Money
2020-07-13,Amgen Pours A Further $421M Into Chinas BeiGene
2020-07-13,BeiGene Plans $2B Direct Offering; Analyst Sees Further Upside Ahead
2020-07-12,Chinese Biotech Beigene to Raise $2.1 Billion in Share Sale
2020-07-12,BeiGene Announces Pricing of Approximately $2.08 Billion Registered Direct Offering
2020-07-10,"Insiders Roundup: Mastercard, Eli Lilly"
2020-07-05,"Is BeiGene, Ltd. (BGNE) A Good Stock To Buy?"
2020-07-02,BeiGene to Host Investor Conference Call and Webcast to Discuss the Companys Early Development Pipeline and Research
2020-07-01,BeiGene Announces Acceptance of a Supplemental New Drug Application for Tislelizumab in Patients with Previously Treated Unresectable Hepatocellular Carcinoma in China
2020-07-01,"The Daily Biotech Pulse: T2 Biosystems Launches COVID-19 Test, Akero Aces Midstage NASH Study, Aravive Added to Russell Indexes"
2020-07-01,BeiGene Announces Appointment of Angus Grant as Chief Business Executive
2020-06-30,BeiGene Begins Commercializing XGEVA® (Denosumab) in China
2020-06-22,BeiGene and SpringWorks Announce Presentation of Preclinical Data Combining RAF Dimer Inhibitor Lifirafenib with MEK Inhibitor Mirdametinib and Provide Update on Ongoing Phase 1b/2 Clinical Trial
2020-06-19,BeiGene Announces Acceptance of a Supplemental New Drug Application for Tislelizumab in Combination with Chemotherapy in First-Line Advanced Non-Squamous Non-Small Cell Lung Cancer in China
2020-06-18,BeiGene Announces European Medicines Agency Acceptance of its Marketing Authorization Application for BRUKINSA® (Zanubrutinib) for the Treatment of Patients with Waldenströms Macroglobulinemia
2020-06-12,BeiGene Presents Clinical Data on Zanubrutinib and Tislelizumab at the 25th European Hematology Association (EHA) Virtual Congress
2020-06-05,BeiGene to Present at the Goldman Sachs 41st Annual Global Healthcare Conference
2020-06-03,BeiGene Announces the Approval of BRUKINSA (Zanubrutinib) in China for Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma and Relapsed/Refractory Mantle Cell Lymphoma
2020-05-29,BeiGene Presents Updated Head to Head Results from Phase 3 Trial of Zanubrutinib vs. Ibrutinib in Patients with Waldenströms Macroglobulinemia at the 2020 American Society of Clinical Oncology (ASCO) Virtual Scientific Program
2020-05-29,BeiGene Presents Phase 3 Data on Tislelizumab Combined with Chemotherapy for the Treatment of Patients with Advanced Squamous Non-Small Cell Lung Cancer at the 2020 American Society of Clinical Oncology (ASCO) Virtual Scientific Program
2020-05-26,BeiGene to Host Investor Conference Call and Webcast to Discuss Clinical Study Results Presented at the 2020 American Society of Clinical Oncology (ASCO) Virtual Scientific Program
2020-05-26,"Chi-Med, BeiGene Join Forces For Solid Cancer Tumor Treatment"
2020-05-26,Chi-Med and BeiGene Enter into Clinical Collaboration to Evaluate Combinations of Surufatinib and Fruquintinib with Tislelizumab
2020-05-21,BeiGene and Medison Pharma Announce Exclusive Distribution Agreement and Acceptance of New Drug Application for BTK Inhibitor BRUKINSA (zanubrutinib) in Israel
2020-05-20,BeiGene to Present at the Bernstein 36th Annual Strategic Decisions Conference
2020-05-15,BeiGene Announces Clinical and Preclinical Data to Be Presented at the 2020 American Association for Cancer Research (AACR) Virtual Annual Meeting II
2020-05-14,Growth Stocks Like Amazon And Tesla Share These Key Metrics: Advisor
2020-05-14,BeiGene Announces Clinical and Non-Clinical Data on BRUKINSA (Zanubrutinib) and Tislelizumab to Be Presented at the 25th European Hematology Association (EHA) Virtual Congress
2020-05-11,BeiGene Reports First Quarter 2020 Financial Results
2020-04-29,BeiGene Announces Clinical Data to Be Presented at the 2020 American Society of Clinical Oncology (ASCO) Annual Meeting
2020-04-20,BeiGene Announces Acceptance of a Supplemental New Drug Application for Tislelizumab in Combination with Chemotherapy in First-Line Advanced Squamous Non-Small Cell Lung Cancer in China
2020-04-13,BeiGene Announces that the Phase 3 Trial of Tislelizumab Combined with Chemotherapy in Patients with First-Line Non-Squamous Non-Small Cell Lung Cancer Met the Primary Endpoint of Progression-Free Survival at Interim Analysis
2020-04-10,China National Medical Products Administration Approves BeiGenes Tislelizumab for Patients with Previously Treated Locally Advanced or Metastatic Urothelial Carcinoma
2020-03-26,"ROSEN, A HIGHLY RANKED FIRM, Continues to Investigate Securities Claims Against BeiGene, Ltd."
2020-03-25,BeiGene Announces Supply Update for ABRAXANE® in China
2020-03-19,"Hedge Funds Are Betting On BeiGene, Ltd. (BGNE)"
2020-03-10,"INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against BeiGene, Ltd. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm"
2020-03-09,"ROSEN, A LEADING LAW FIRM, Continues to Investigate Securities Claims Against BeiGene, Ltd.  BGNE"
2020-03-07,Coronavirus Outbreak Could Disrupt Drug Companies Clinical Trials
2020-03-02,BeiGene Reports Fourth Quarter and Full Year 2019 Financial Results
2020-02-27,"MapKure, BeiGene and SpringWorks Announce Initiation of Phase 1 Clinical Trial of BGB-3245, a Selective Next-Generation B-RAF Inhibitor, in Adult Patients with Advanced or Refractory Solid Tumors"
2020-02-25,BeiGene to Present at the Cowen and Companys 40th Annual Health Care Conference
2020-02-18,Amgen Inc. -- Moody's assigns Baa1 rating to Amgen's new sr. unsecured notes; stable outlook
2020-01-21,BeiGene Announces that the Phase 3 Clinical Trial of its Anti-PD-1 Antibody Tislelizumab in Patients with First-Line Squamous Non-Small Cell Lung Cancer Met the Primary Endpoint of Progression-Free Survival at Interim Analysis
2020-01-13,EUSA Pharma and BeiGene Announce Exclusive Development and Commercialization Agreement for SYLVANT® and QARZIBA® in Greater China
2020-01-08,BeiGene to Present at the 38th Annual J.P. Morgan Healthcare Conference
2020-01-06,Leap Therapeutics Surges on License Agreement With BieGene
2020-01-03,Cash-strapped biotech signs deal with Chinese drugmaker BeiGene
2020-01-03,Leap Therapeutics and BeiGene Announce Exclusive Option and License Agreement for DKN-01 and Leap Announces $27 Million Equity Financing
2020-01-02,BeiGene Announces Closing of Amgen Global Strategic Oncology Collaboration and Equity Investment
2019-12-30,BeiGene Gets Approval for Lymphoma Drug Tislelizumab in China
2019-12-28,"ROSEN, NATIONAL TRIAL LAWYERS, Continues to Investigate Securities Claims Against BeiGene, Ltd.  BGNE"
2019-12-27,China National Medical Products Administration Approves BeiGenes Tislelizumab for Patients with Classical Hodgkins Lymphoma Who Have Received at Least Two Prior Therapies
